Scarica l'app Stockscreener
0.478
2.83%
-0.0139
Dopo l'orario di chiusura:
.48
0.002
+0.42%
Precedente Chiudi:
$0.4919
Aprire:
$0.48
Volume 24 ore:
68,537
Relative Volume:
0.34
Capitalizzazione di mercato:
$5.36M
Reddito:
$19.98M
Utile/perdita netta:
$-2.66M
Rapporto P/E:
-1.1696
EPS:
-0.4087
Flusso di cassa netto:
$-2.65M
1 W Prestazione:
-0.62%
1M Prestazione:
-15.55%
6M Prestazione:
-28.68%
1 anno Prestazione:
-29.92%
Intervallo 1D:
$0.475
$0.50
Intervallo di 1 settimana:
$0.4744
$0.505
Portata 52W:
$0.4521
$2.56
cbdMD Inc Stock (YCBD) Company Profile
Nome
cbdMD Inc
Settore
Telefono
704-445-5800
Indirizzo
4521 Sharon Road, Charlotte, NC
Compare YCBD vs TAK, TEVA, HLN, ZTS, UTHR
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
YCBD
cbdMD Inc
|
0.478 | 5.51M | 19.98M | -2.66M | -2.65M | -0.4087 |
TAK
Takeda Pharmaceutical Co Adr
|
18.11 | 58.15B | 29.91B | 1.30B | 3.49B | 0.4056 |
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
36.35 | 42.94B | 17.53B | 1.58B | 444.18M | 1.3457 |
HLN
Haleon Plc Adr
|
9.22 | 40.59B | 14.54B | 2.22B | 2.58B | 0.4871 |
ZTS
Zoetis Inc
|
72.86 | 30.29B | 9.51B | 2.64B | 2.14B | 6.0361 |
UTHR
United Therapeutics Corp
|
503.86 | 21.74B | 3.17B | 1.29B | 1.01B | 27.09 |
cbdMD Inc Borsa (YCBD) Ultime notizie
Cbdmd Stock Price Forecast. Should You Buy YCBD? - StockInvest.us
cbdMD to buy Twinlab as supplement M&A heats up - SupplySide Supplement Journal
YCBD Q2 2026 Earnings: Deep Loss Miss Raises Questions as Shares Fall 3.76%Revenue Growth Outlook - vinanet.vn
cbdMD Q3FY26 sales miss $5.689M estimate; EPS $(0.11) - scanx.trade
cbdMD to Acquire Twinlab's Legacy Supplement Brands - Nutritional Outlook
cbdMD to Acquire Twinlab Brands, Expanding Consumer Wellness Portfolio - citybiz
CbdMD, Inc. entered into a definitive asset purchase agreement to acquire Operating assets and brands of Twinlab Consolidation Corporation for $2.9 million. - marketscreener.com
cbdMD acquires legacy supplement brand Twinlab - NutraIngredients.com
cbdMD’s Acquisition of Supplement Legacy Brand Twinlab Creates Unique Synergy - WholeFoods Magazine
cbdMD agrees to acquire Twinlab brands - Chain Drug Review
Twinlab Sets Asset Sale to cbdMD for $3.98 Million; Consideration Goes to Akretive - TradingView
cbdMD to acquire Twinlab supplement brands for $30M revenue boost - Investing.com Nigeria
cbdMD to acquire Twinlab brands, boosting reven... - Pluang
cbdMD Enters Definitive Agreement to Acquire Twinlab Brands, Expanding Into Legacy Supplements, Sports Nutrition, Women's Beauty, Weight Loss and Longevity Wellness - PR Newswire
cbdMD to Acquire Twinlab Assets; Will Assume $1.75M Debt and Issue 19.9% New Shares - TradingView
YCBD | cbdMD, Inc. Common Stock FinancialsRevenue Breakdown - Quiver Quantitative
cbdMD (YCBD) Results at a Glance: EPS Does Not Reach the Reported Estimate in the Available Record; Post-Report: The Market Price Advances 0.79% in the Latest ReadingAnalyst Drop Coverage - siam.in
cbdMD Inc (YCBD) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
cbdMD Inc (YCBD) Stock News Today - TradingKey
Maxim Group Downgrades CbdMD(YCBD.US) to Hold Rating, Cuts Target Price to $0.5 - Moomoo
YCBD Downgraded by Maxim Group -- Rating Changed to Hold - GuruFocus
Maxim Group Downgrades cbdMD to Hold From Buy - marketscreener.com
Conferencia de resultados del T3 fiscal de 2026 de CBDMD (YCBD): los ingresos aumentan un 20%, objetivo de reducción de costos - TradingKey
YCBD|cbdMD Inc|Price:0.470|Chg%:-0.005 - TradingKey
cbdMD Inc (YCBD) (Q3 2026) Earnings Call Highlights: Strategic Pivot and Cost Cuts Aim to ... - Yahoo Finance
YCBD Q3 FY2026 earnings call - finance.biggo.com
cbdMD Q3 2026 Earnings Call: Complete Transcript - Benzinga
Earnings call transcript: cbdMD misses Q3 2026 EPS as shares fall after hours - Investing.com
Transcript : CbdMD, Inc., Q3 2026 Earnings Call, Aug 13, 2026 - marketscreener.com
cbdMD Q3 FY2026 Earnings: Revenue Grows 20% as Gross Margin Narrows - TradingKey
cbdMD Reports 20% Year-over-Year Revenue Growth for the Third Fiscal Quarter of 2026 - PR Newswire
cbdMD, Inc. (NYSE: YCBD) grows sales to $16.2M amid going concern warning - Stock Titan
cbdMD (NYSE American:YCBD): What Does the Latest Update Mean for Brand Demand? - Kalkine Media
cbdMD reports 20% revenue growth in Q3 2026, dr... - Pluang
cbdMD Inc (YCBD) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
cbdMD schedules conference call on quarterly results - Bitget
cbdMD schedules 4:20 p.m. call to discuss June 30 results - Stock Titan
cbdMD to discuss Q3 2026 financial results in c... - Pluang
cbdMD Inc. (YCBD) Holds Steady at $0.58 as Traders Eye Key $0.55–$0.61 RangePoint of Control - vinanet.vn
CBD Gummy Bears Stock SymbolView gF7h08LSE - Diario AS
Senate bill proposes delay of hemp product restrictions By Investing.com - Investing.com UK
cbdMD Inc. (YCBD) Surges 12% to $0.57: Key Levels to WatchChart Pattern Alerts - dars.gov.et
cbdMD Applauds Proposed SENATE SPENDING BILL That Would Protect Access to Full-Spectrum CBD and Other Naturally Derived Hemp Products - TradingView
Cbdmd Cbd Oil Tincture Review: What Customers Are Saying Fall 2026 [WY2QyUdh5WG] - Diario AS
YCBD|cbdMD Inc|Price:0.507|Chg%:+0.034 - TradingKey
cbdMD Inc (YCBD) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
cbdMD Inc. (YCBD) Treads Water Near Support Level as Price Ekes Out Slight GainFibonacci Entry Signals - vinanet.vn
cbdMD Inc. (YCBD) Faces Selling Pressure as Stock Tests Key Support LevelsFibonacci Extension - vinanet.vn
cbdMD Inc (YCBD) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
cbdMD Inc (YCBD) Valuation: PE, PB & Fair Value Analysis - TradingKey
cbdMD Inc (YCBD) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
cbdMD Inc Azioni (YCBD) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.56%
1.43%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):